CAXTON CORP 13D and 13G filings for Sierra Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:57 pm Sale | 2021-12-31 | 13G | Sierra Oncology, Inc. SRRA | CAXTON CORP | 1,119,322 7.000% | -23,039 (-2.02%) | Filing |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Sierra Oncology, Inc. SRRA | CAXTON CORP | 1,142,361 9.900% | 60,161 (+5.56%) | Filing |